Hostname: page-component-76fb5796d-vvkck Total loading time: 0 Render date: 2024-04-26T07:24:02.248Z Has data issue: false hasContentIssue false
  • English
  • Français

The impact of cinnarizine and griseofulvin on juvenile and adult stages of Schistosoma mansoni

Published online by Cambridge University Press:  26 February 2019

R.M. Sarhan Open the ORCID record for R.M. Sarhan [Opens in a new window] ,
H.S. Thabet ,
J.T. Nazeer  and
S. William
R.M. Sarhan*
Affiliation:
Faculty of Medicine, Ain Shams University, Cairo, Egypt
H.S. Thabet
Affiliation:
Faculty of Medicine, Ain Shams University, Cairo, Egypt
J.T. Nazeer
Affiliation:
Faculty of Medicine, Ain Shams University, Cairo, Egypt
S. William
Affiliation:
Theodor Bilharz Research Institute, Giza, Egypt
*
Author for correspondence: R.M. Sarhan E-mail: raniasarhan99@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Schistosomiasis affects millions globally. There is no vaccine, and treatment depends entirely on praziquantel (PZQ). Field isolates exhibit reduced susceptibility to PZQ, and resistance has been experimentally induced, suggesting that reliance on a single treatment is particularly dangerous. The present study investigated the value of cinnarizine and griseofulvin against Schistosoma mansoni through their in vitro effects on adult worms and oviposition as well as in vivo evaluation in early and late infection, compared to PZQ, in a preliminary experimental model. In vitro, both cinnarizine and griseofulvin showed uncoupling, sluggish worm movement and complete absence of ova at 100 μg/ml. In early infection, cinnarizine showed a significant reduction in the number of porto-mesenteric couples compared to the griseofulvin and control groups, a finding similar to PZQ. Remarkably, cinnarizine significantly exceeded PZQ and griseofulvin in reducing the total worm burden. In late infection, cinnarizine and griseofulvin showed results similar to PZQ by significantly reducing the numbers of hepatic and porto-mesenteric couples and total worm burden compared to controls. Cinnarizine performed better than griseofulvin by reducing hepatic and intestinal ovum counts, and it led to complete disappearance of the first two immature stages. The current work suggests the possibility of using cinnarizine and griseofulvin, mainly in late S. mansoni infection, especially cinnarizine, which showed similar results to PZQ and surpassed it in early infection. Further studies are required to elucidate their exact mechanisms of action and particularly their synergistic effect with PZQ.

Keywords

anthelminticcinnarizinegriseofulvinin vitroin vivopraziquantelSchistosoma mansoni
Type
Research Paper
Information
Journal of Helminthology , Volume 94 , 2020 , e41
Copyright
Copyright © Cambridge University Press 2019 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Andrews, P (1985) Praziquantel: mechanisms of antischistosomal activity. Pharmacology & Therapeutics 29,129–156.Google Scholar
Badria, F et al. (2001) Mirazid: a new schistosomicidal drug. Pharmaceutical Biology 39, 127–131.Google Scholar
Bertão, HG et al. (2012) Ultrastructural analysis of miltefosine-induced surface membrane damage in adult Schistosoma mansoni BH strain worms. Parasitology Research 110, 2465–2473.Google Scholar
Bonn, D (2004) Schistosomiasis: a new target for calcium channel blockers? The Lancet Infectious Diseases 4, 190.Google Scholar
Botros, SS et al. (2005) Effect of praziquantel on the immature stages of Schistosoma haematobium. International Journal for Parasitology 3, 1453–1457.Google Scholar
Botros, SS et al. (2009) Antischistosomal activity of hexadecyloxypropyl cyclic 9-(S)- [3-hydroxy-2-(phosphonomethoxy) propyl adenine and other alkoxyalkyl esters of acyclic nucleoside phosphonates assessed by schistosome worm killing in vitro. Antimicrobial Agents and Chemotherapy 53, 5284–5287.Google Scholar
Brindley, PJ and Hotez, PJ (2013) Break out: urogenital schistosomiasis and Schistosoma haematobium infection in the post-genomic era. PLoS Neglected Tropical Diseases 7, e1961.Google Scholar
Caffrey, CR (2015) Schistosomiasis and its treatment. Future Medicinal Chemistry 7, 675–676.Google Scholar
Cheever, AW (1968) Conditions affecting the accuracy of potassium hydroxide digestion techniques for counting Schistosoma mansoni eggs in tissues. Bulletin of the World Health Organization 39, 328–331.Google Scholar
Cioli, D et al. (2014) Schistosomiasis control: praziquantel forever? Molecular and Biochemical Parasitology 195, 23–29.Google Scholar
Cohen, CJ, Spires, S and Van Skiver, D (1992) Block of T-type Ca channels in guinea pig atrial cells by antiarrhythmic agents and Ca channel antagonists. General Physiology and Biophysics 100, 703–728.Google Scholar
Colley, DG et al. (2014) Human schistosomiasis. The Lancet 383, 2253–2264.Google Scholar
de Moraes, J et al. (2014) Phytol, a diterpene alcohol from chlorophyll, as a drug against neglected tropical disease schistosomiasis mansoni. PLoS Neglected Tropical Diseases 8, e2617.Google Scholar
Delgado, VS et al. (1992) Experimental chemotherapy of Schistosoma mansoni with praziquantel and oxamniquine: differential effect of single or combined formulations of drugs on various strains and on both sexes of the parasite. Parasitology Research 78, 648–654.Google Scholar
de Oliveira, RN et al. (2014) Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni. Experimental Parasitology 139, 63–72.Google Scholar
de Oliveira, RN et al. (2012) Schistosoma mansoni: in vitro schistosomicidal activity of essential oil of Baccharis trimera (less) DC. Experimental Parasitology 132, 135–143.Google Scholar
Doenhoff, MJ, Cioli, D and Utzinger, J (2008) Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Current Opinion in Infectious Diseases 21, 659–667.Google Scholar
Duvall, RH and De Witt, WB (1967) Technique for recovering adult schistosomes from laboratory animals. The American Journal of Tropical Medicine and Hygiene 16, 438–486.Google Scholar
Frezza, TF et al. (2013) Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay. Acta Tropica 128, 70–75.Google Scholar
Frezza, TF et al. (2015) Effectiveness of hyperbaric oxygen for experimental treatment of schistosomiasis mansoni using praziquantel-free and encapsulated into liposomes: assay in adult worms and oviposition. Acta Tropica 150, 182–189.Google Scholar
Greenberg, RM (2005) Are Ca2+ channels targets of praziquantel action? The International Journal for Parasitology 35, 1–9.Google Scholar
Greenberg, RM (2013) New approaches for understanding mechanisms of drug resistance in schistosomes. Parasitology 140, 1534–1546.Google Scholar
Hotez, PJ and Fenwick, A (2009) Schistosomiasis in Africa: an emerging tragedy in our new global health decade. PLoS Neglected Tropical Diseases 3, e485.Google Scholar
Jiraungkoorskul, W et al. (2005) Effects of praziquantel and artesunate on the tegument of adult Schistosoma mekongi harbored in mice. Parasitology International 54, 177–183.Google Scholar
Kamel, ROA and Bayaumy, FEA (2017) Ultrastructural alterations in Schistosoma mansoni juvenile and adult male worms after in vitro incubation with primaquine. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro 112, 247–254.Google Scholar
Keiser, J et al. (2009) Mefloquine an aminoalcohol with promising antischistosomal properties in mice. PLoS Neglected Tropical Diseases 3, e350.Google Scholar
Kramer, CV et al. (2013) Drugs for treating urinary schistosomiasis. Cochrane Database of Systematic Reviews 2013, CD000053.Google Scholar
Liang, YS, John, BI and Boyd, DA (1987) Laboratory cultivation of schistosome vector snails and maintenance of schistosome life cycles. Proceedings of the 1st Sino-American Symposium 1, 34–48.Google Scholar
Li, S et al. (1996) Studies on prophylactic effect of artesunate on schistosomiasis japonica. Chinese Medical Journal (Engl) 109, 848–853.Google Scholar
Manneck, T, Haggenmuller, Y and Keiser, J (2010) Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni. Parasitology 137, 850–898.Google Scholar
Mitsui, Y, Miura, M and Aoki, Y (2009) In vitro effects of artesunate on the survival of worm pairs and egg production of Schistosoma mansoni. Journal of Helminthology 83, 7–11.Google Scholar
Moraes, J (2012) Antischistosomal natural compounds: present challenges for new drug screens. In AJ, Rodriguez-Morales (ed.), Current Topics in Tropical Medicine. Rijeka: Intech, pp. 333–358.Google Scholar
Mostafa, OMS (2005) Effects of sedr honey and/or black-seed oil on Schistosoma mansoni in albino mice: parasitological, biochemical and scanning electron microscopical studies. The Egyptian Journal of Experimental Biology (Zoology) 45, 449–469.Google Scholar
Nessim, NG et al. (2000) Effect of the broad spectrum anthelmintic drug flubendazole upon Schistosoma mansoni experimentally infected mice. Arzneimittel-Forschung 50, 1129–1133.Google Scholar
Neves, BJ et al. (2015) In silico repositioning-chemogenomics strategy identifies new drugs with potential activity against multiple life stages of Schistosoma mansoni. PLoS Neglected Tropical Diseases 9, e34–35.Google Scholar
Noël, F et al. (2001) Control of calcium homeostasis in Schistosoma mansoni. Memórias do Instituto Oswaldo Cruz 96 (Suppl.), 85–88.Google Scholar
Oxford, AE, Raistrick, H and Simonart, P (1939) Studies in the biochemistry of micro-organisms: griseofulvin, C (17) H (17) O (6) Cl, a metabolic product of penicillium griseo-fulvum Dierckx. Biochemistry Journal 33, 240–248.Google Scholar
Pax, R, Bennett, JL and Fetterer, R (1978) A benzodiazepine derivative and praziquantel: effects on musculature of Schistosoma mansoni and Schistosoma japonicum. Naunyn-Schmiedeberg's Archives of Pharmacology 304, 309–315.Google Scholar
Pellegrino, J et al. (1962) New approach to the screening of drugs in experimental schistosomiasis mansoni in mice. The American Journal of Tropical Medicine and Hygiene 11, 201–215.Google Scholar
Pica-Mattoccia, L and Cioli, D (2004) Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment. The International Journal for Parasitology 34, 527–533.Google Scholar
Ramirez, B et al. (2007) Schistosomes: challenges in compound screening. Expert Opinion on Drug Discovery 2, S53–S61.Google Scholar
Rathinasamy, K et al. (2010) Griseofulvin stabilizes microtubule dynamics, activates p53 and inhibits the proliferation of MCF-7 cells synergistically with vinblastine. Biomedcentral Cancer 10, 213.Google Scholar
Rebacz, B et al. (2007) Identification of griseofulvin as an inhibitor of centrosomal clustering in a phenotype-based screen. Cancer Research 67, 6342–6350.Google Scholar
Redman, CA, Robertson, A and Fallon, PG (1996) Praziquantel: an urgent and exciting challenge. Parasitology Today 12, 14–20.Google Scholar
Riad, NH, Taha, HA and Mahmoud, YI (2009) Effects of garlic on albino mice experimentally infected with Schistosoma mansoni; a parasitological and ultrastructural study. Tropical Biomedicine 26, 40–50.Google Scholar
Rollinson, D et al. (2013) Time to set the agenda for schistosomiasis elimination. Acta Tropica 128, 423–440.Google Scholar
Salvador-Recatalà, V, Schneider, T and Greenberg, RM (2008) Atypical properties of a conventional calcium channel beta subunit from the platyhelminth Schistosoma mansoni. Biomedcentral Physiology 8, 6.Google Scholar
Shaohong, L et al. (2006) Evaluation of the anthelmintic effects of artesunate against experimental Schistosoma mansoni infection in mice using different treatment protocols. Parasitology International 55, 63–68.Google Scholar
Shaw, MK and Erasmus, DA (1988) Schistosoma mansoni: praziquantel induced changes to the female reproductive system. Experimental Parasitology 65, 31–42.Google Scholar
Silva-Moraes, V et al. (2013) Antischistosomal activity of a calcium channel antagonist on schistosomula and adult Schistosoma mansoni worms. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro 108, 600–604.Google Scholar
Singh, BN (1986) The mechanism of action of calcium antagonists relative to their clinical applications. British Journal of Clinical Pharmacology 21, 109S–121S.Google Scholar
Thetiot-Laurent, SA et al. (2013) Schistosomiasis chemotherapy. Agnewandte Chemie 52, 7936–7956.Google Scholar
Uen, YH et al. (2007) NF-kappa B pathway is involved in griseofulvin-induced G2/M arrest and apoptosis in HL-60 cells. Journal of Cellular Biochemistry 101, 1165–1175.Google Scholar
Vale, N et al. (2017) Praziquantel for schistosomiasis: single drug metabolism revisited, mode of action, and resistance. Antimicrobial Agents and Chemotherapy 61, e02582–16.Google Scholar
Walter, M and Kuris, A (2003) Methods for the inhibition of egg production in trematodes. USA patent 6,514,963. B2.Google Scholar
Wang, W, Wang, L and Liang, YS (2012) Susceptibility or resistance of praziquantel in human schistosomiasis: a review. Parasitology Research 111, 1871–1877.Google Scholar
WHO (World Health Organization) (2018) Schistosomiasis. http://www.who.int/news-room/fact-sheets/detail/schistosomiasis.Google Scholar
William, S, Guirguis, F and Nessim, NG (2003) Effect of simultaneous and/or consecutive administration of the broad spectrum anthelmintic flubendazole together with praziquantel in experimental Schistosoma mansoni infection. Arzneimittel-Forschung 53, 532–537.Google Scholar
Yang, Z et al. (2013) Parasitic nematode-induced modulation of body weight and associated metabolic dysfunction in mouse models of obesity. Infection and Immunity 81, 1905–1914.Google Scholar
Supplementary material: File

Sarhan et al. supplementary material

Sarhan et al. supplementary material 1

Download Sarhan et al. supplementary material(File)
File 15.4 KB